The research outcomes and technologies are obtained by a complex R&D formation, and the fields include a wide range from basic science to clinical study such as immunology, cell engineering, molecular biology and genetic engineering, and also include the apparatuses, systems and other the peripheral technologies.
In order to accelerate its business further and to nurture new business seeds using such technologies, MEDINET utilizes intellectual properties based on the following guidelines.
1. To build intellectual property rights consisting of basic, applied and defensive technology.
2. To achieve an intelligent property portfolio that is most suitable for MEDINET.
3. To utilize the intelligent property in considering licensing-in/out of the property.
[Current Situation of the Intelligent Properties]
We have filed 35 patent applications until now* (of these 9 are overseas applications, and 1 are Japan and overseas applications**.) These numbers include the number of unpublished patent applications.
* September 30, 2011
** A patent application for a patent to cover all over world including Japan.
| Registered patents |
4 in Japan |
| JP4031932 |
Donor identifying method and biological material identification means |
| JP4136350 |
Medical care supporting system |
| JP4557886 |
Esophageal cancer antigen and utilization thereof |
| JP4668568 |
Culture vessel, culture apparatus, and method for culturing cell |
| 2 in foreign countries |
| EP1536006 |
Cancer antigens and utilization thereof |
| AU2005260887 |
Dendritic cells, drug containing the dendritic cell, therapeutic method using the dendritic cell and method of culturing gamma-delta T cell |
| Published patent applications |
WO2006/006638 |
Dendritic cells, drug containing the dendritic cell, therapeutic method using the dendritic cell and method of culturing gamma-delta T cell |
| WO2006/006720 |
Method of culturing gamma-delta T cells, gamma-delta T cells and
remedy/preventive |
| WO2006/011681 |
Preservation method and transport method for blood for leucocyte incubation, preservation method and transport method for peripheral blood monocytes and method of incubation leucocytes using the same |
| WO2006/011682 |
Method of preserving and transporting lymphocytes |
| JP2011-139711 |
Method of preserving and transporting lymphocytes |
| WO2006/101056 |
Cell culture evaluating system, cell culture evaluation method, and cell culture evaluation program |
| WO2007/029689 |
Method for activation treatment of antigen-presenting cell |
| WO2007/052716 |
Cell culture apparatus, cell culture method, cell culture program and cell culture system |
| WO2007/052718 |
Shaker for cell culture and shaken culture system in cell culture method |
| WO2008/129874 |
Method of targeting tumor cell and use of the same |
| WO2008/152822 |
Medicinal Agent |
| WO2009/113649 |
Antibody having an immune-enhancement function |
| WO2010/001599 |
Method for simultaneous induction of CTL and gamma-delta T cell |
| WO2010/047117 |
Novel monoclonal antibody and use thereof |
| WO2010/126081 |
Method for solubilizing insoluble protein and/or peptide |
| JP2010-259373 |
Method for activation treatment of antigen-presenting cell |
| WO2010/150708 |
Protein modifying agent |
| WO2004/020624 |
Cancer antigens and utilization thereof |
| JP2010-159257 |
Cancer antigens and utilization thereof |
| WO2007/018198 |
Cancer rejection antigen peptide derived from HSP105 for use in HLA-A2 positive patient and pharmaceutical composition comprising the antigen |
